18:24 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Manglam Drugs and Organics Ltd. has appointed M/s S.N. Nanda & Co. as Statutory Auditor and M/s L.N. Joshi & Co. as Secretarial Auditor.
Mangalam Drugs and Organics Ltd
- Share price
- ₹33.09
- Market cap
- ₹52.38 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.4×Sector 47.3×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Debt & Borrowing 4Management Change 3Other Announcement 2Legal & Regulatory 2Annual General Meeting 2Financial Results 1Board Meeting Outcome 1Board Meeting Date 1
Time
3 announcements with these filters
16:33 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics Limited has appointed Mr. Prabhakar Raghunath Zavar as a Non-Executive Independent Director, effective September 15, 2026.
17:56 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics Limited announced the cessation of its Secretarial Auditor, M/s. Ragini Chokshi & Co., due to resignation effective August 4, 2026.